Literature DB >> 17624313

Fine mapping of the NRC-1 tumor suppressor locus within chromosome 3p12.

Kun Zhang1, Steven T Lott, Li Jin, Ann McNeill Killary.   

Abstract

Identification of tumor suppressor genes based on physical mapping exercises has proven to be a challenging endeavor, due to the difficulty of narrowing regions of loss of heterozygosity (LOH), infrequency of homozygous deletions, and the labor-intensive characterization process for screening candidates in a given genomic interval. We previously defined a chromosome 3p12 tumor suppressor locus NRC-1 (Nonpapillary Renal Carcinoma-1) by functional complementation experiments in which renal cell carcinoma microcell hybrids containing introduced normal chromosome 3p fragments were either suppressed or unsuppressed for tumorigenicity following injection into athymic nude mice. We now present the fine-scale physical mapping of NRC-1 using a QPCR-based approach for measuring copy number at sequence tagged sites (STS) which allowed a sub-exon mapping resolution. Using STS-QPCR and a novel statistical algorithm, the NRC-1 locus was narrowed to 4.615-Mb with the distal boundary mapping within a 38-Kb interval between exon 3 and exon 4 of the DUTT1/Robo1 gene, currently the only candidate tumor suppressor gene in the interval. Further mutational screening and gene expression analyses indicate that DUTT1/ROBO1 is not involved in the tumor suppressor activity of NRC-1, suggesting that there are at least two important tumor suppressor genes within the chromosome 3p12 interval.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17624313     DOI: 10.1016/j.bbrc.2007.06.066

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  A migration signature and plasma biomarker panel for pancreatic adenocarcinoma.

Authors:  Seetharaman Balasenthil; Nanyue Chen; Steven T Lott; Jinyun Chen; Jennifer Carter; William E Grizzle; Marsha L Frazier; Subrata Sen; Ann McNeill Killary
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-11

Review 2.  DEAR1, a novel tumor suppressor that regulates cell polarity and epithelial plasticity.

Authors:  Nanyue Chen; Seetharaman Balasenthil; Jacquelyn Reuther; Ann McNeill Killary
Journal:  Cancer Res       Date:  2014-09-26       Impact factor: 12.701

3.  VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer.

Authors:  Karen Gambaro; Michael C J Quinn; Paulina M Wojnarowicz; Suzanna L Arcand; Manon de Ladurantaye; Véronique Barrès; Jean-Sébastien Ripeau; Ann M Killary; Elaine C Davis; Josée Lavoie; Diane M Provencher; Anne-Marie Mes-Masson; Mario Chevrette; Patricia N Tonin
Journal:  Mol Oncol       Date:  2013-01-16       Impact factor: 6.603

4.  Identification of genetic variants predictive of early onset pancreatic cancer through a population science analysis of functional genomic datasets.

Authors:  Jinyun Chen; Xifeng Wu; Yujing Huang; Wei Chen; Randall E Brand; Ann M Killary; Subrata Sen; Marsha L Frazier
Journal:  Oncotarget       Date:  2016-08-30

5.  DEAR1 is a dominant regulator of acinar morphogenesis and an independent predictor of local recurrence-free survival in early-onset breast cancer.

Authors:  Steven T Lott; Nanyue Chen; Dawn S Chandler; Qifeng Yang; Luo Wang; Marivonne Rodriguez; Hongyan Xie; Seetharaman Balasenthil; Thomas A Buchholz; Aysegul A Sahin; Katrina Chaung; Baili Zhang; Shodimu-Emmanu Olufemi; Jinyun Chen; Henry Adams; Vimla Band; Adel K El-Naggar; Marsha L Frazier; Khandan Keyomarsi; Kelly K Hunt; Subrata Sen; Bruce Haffty; Stephen M Hewitt; Ralf Krahe; Ann McNeill Killary
Journal:  PLoS Med       Date:  2009-05-05       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.